Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synaptic Density in Psychiatric Disorders Using SV2A Receptor PET Imaging With [11C]APP311

NCT03995121 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03995121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03995121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synaptic Density in Psychiatric Disorders Using SV2A Receptor PET Imaging With [11C]APP311
Lead sponsor
Yale University
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2017
Completion date
December 31, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder, healthy, schizophrenia and other psychotic disorders